Zoloact - Essay Example

Website Zoloact website will comprise of a number of components whose aims are to market the drug. One of themain components of the website will be a distinguishing logo for the drug. The logo will have a unifying graphic around it, which resemble that of the drugs packaging. The website will also comprise of images, graphics, triangulation bars, and animations of Zoloact. Additionally, the website will include a shopping cart, which will allow potential customers to order the drugs when they access our websites.

Furthermore, the website will include the prescriptions necessary for the drug and the diseases that are cured by the drug. Still, Zoloact website will include a review section whereby patients who have used the drug will give a response on drug use experience. Besides, an inquiry section will be developed where patients can ask questions related to the drug. Market Research Zoloact, as a bisphosphonate drug faces various threats and competition from its competing drugs. Alendronate (Web) notes that the current market valuation of bisphosphonate drug is $ 4.6 billion. However, the market demand of the drug is expected to decrease by 5-7 % each year (Alendronate Web).

This is because of the increased awareness of the need to keep healthy by eating calcium containing food components for the elderly. Zoloact, as a bisphosphonate alternative drug, will aim at providing the best medical care to such patients by ensuring that the drug prevents loss of bone mass to the elderly. Bisphosphonate drugs are expected to lose more that 30% of their entire market share from competition from other substitute drugs such as Zoloact, in addition to medical regulations that govern the components of these drugs.

The drug will prove to be a patient’s favorite due to its generic components, which also takes the form of bisphonate injection. Moreover, bisphosphonate drugs experience seasonality within their maturity and growth stages thus making zoloact a favorite substitute. However, emerging markets in developing countries such as Spain are expected to increase thus offering redemption to the dwindling market in the country. Zoloact will venture into the new emerging markets as well as venturing into the now dwindling market for the bisphosphonate drugs.

Development of the Drug Due to the increased costs to develop the drug, we will require to liaise with partners to develop the drug. Such partners will include medical research institutes such as the center for disease control and prevention, and the World Health Organization requirements. Moreover, we will seek partnership with like-minded drug developers whose aims and objectives are to develop generic composed drugs that aim to reduce the decreasing bone mass of the elderly. Forming partnerships and joint ventures of the drug will enhance effectiveness and efficiency in the development efforts of Zoloact.

Moreover, it will provide access to crucial resources such as expertise, and develop relationships that would otherwise be inaccessible to us. Joint ventures in the development of this drug will produce new knowledge that will inform us on the development. In partnership, learning is the key component, which we will derive from our intended partnership. In order to develop effective partnerships, our team will have to develop trust between parties involved in the development process of the drug.

Moreover, the team will have to provide cooperative interpersonal relationships with the development partners. In addition, active communication will be of the essence to develop the drug. Works Cited Alendronate. Bisphosphonate Drugs. Alendronate. Web 23, September 2012< http://www.alendronate.org/bisphosphonates.htm>